RxDoctor Payments Data

Jared Seale, MD

Orthopaedic Surgery of the Spine · Little Rock, ARNPI 1932242153

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $809,458 of the $1,032,479 with a category attached, or 78.4%. Medtronic accounts for 96.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $267,732 and has fallen 76.2% since, to $63,738 in 2025.

$1,032,479in general payments, 2019–2025

Across 839 payments — averaging $1230.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$991K
  • Stryker$32K
  • Si-bone, Inc.$8K
  • Expanding Innovations, Inc.$2K
  • DJO, LLC$292
  • Globus Medical$273
  • plus $92 from 4 others
$268,051in research payments, 2019–2025

Across 24 payments — averaging $11,169 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$268K
$1,499in ownership & investment interests, 2019–2025

Across 1 payment — averaging $1498.90 each. An ownership or investment interest held by the physician or an immediate family member.

  • Expanding Innovations, Inc.$1K

What the payments were for

  • Consulting fees$124,09712%
  • Speaking & faculty fees$809,45878%
  • Travel & lodging$85,5738%
  • Food & beverage$13,3501%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)803$990,664
Stryker16$31,507
Si-bone, Inc.1$8,050
Expanding Innovations, Inc.2$1,601
DJO, LLC11$292
Globus Medical1$273
Amgen2$32
Abbott1$23
Spinal Elements, Inc.1$21
Boston Scientific1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic surgery of the spine providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$411,447
Medicare patients
337
Services billed
1,648

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin237$3,481
Tizanidine Hcl315$2,778
Methylprednisolone72$503
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen60$440
Oxycodone Hcl87$401
Pregabalin17$329
Tramadol Hcl57$188
Diclofenac Sodium16$141
Meloxicam27$126
Cyclobenzaprine Hcl14$94
Alprazolam19$15

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →